Investor Samlyn Capital, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Samlyn Capital, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-14 13G/A PCT / PureCycle Technologies, Inc. 11,668,311 16,699,862
2025-08-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 4,065,935 0
2025-05-15 13G/A VINP / Vinci Compass Investments Ltd. 2,360,265 2,356,733
2025-05-15 13G/A NKTR / Nektar Therapeutics 9,667,048 0
2025-05-15 13G/A CRVS / Corvus Pharmaceuticals, Inc. 6,667,105 4,065,935
2025-02-14 13G/A VINP / Vinci Compass Investments Ltd. 2,629,571 2,360,265
2025-02-14 13G/A INZY / Inozyme Pharma, Inc. 3,372,558 0
2025-02-14 13G/A PCT / PureCycle Technologies, Inc. 14,852,713 11,668,311
2025-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 6,263,758 6,667,105
2025-02-14 13G NKTR / Nektar Therapeutics 9,667,048
2024-11-14 13G/A MRUS / Merus N.V. 3,412,410 2,610,393
2024-11-01 13D/A AMNL / Applied Minerals, Inc. 85,144,328 96,681,256
2024-09-20 13G/A PCT / PureCycle Technologies, Inc. 9,024,208 14,852,713
2024-08-01 13G/A CRVS / Corvus Pharmaceuticals, Inc. 6,267,984 6,263,758
2024-05-13 13G/A CRVS / Corvus Pharmaceuticals, Inc. 2,496,259 6,267,984
2024-03-11 13D/A AMNL / Applied Minerals, Inc. 85,144,328 85,144,328
2024-02-14 13G/A VINP / Vinci Compass Investments Ltd. 2,381,887 2,629,571
2024-02-14 13G/A PCT / PureCycle Technologies, Inc. 11,544,670 9,024,208
2024-02-14 13G MRUS / Merus N.V. 3,412,410
2024-02-14 13G INZY / Inozyme Pharma, Inc. 3,372,558
2024-02-14 13G CRVS / Corvus Pharmaceuticals, Inc. 2,496,259
2024-01-05 13D/A AMNL / Applied Minerals, Inc. 79,126,740 85,144,328
2023-02-14 13G/A ELYM / Eliem Therapeutics, Inc. 2,128,202 0
2023-02-14 13G/A GLHA / Glass Houses Acquisition Corp - Class A 1,260,198 0
2023-02-14 13G/A PWP / Perella Weinberg Partners 2,993,365 0
2023-02-14 13G VINP / Vinci Compass Investments Ltd. 2,381,887
2023-02-14 13G PCT / PureCycle Technologies, Inc. 11,544,670
2023-02-14 13G/A STSA / Satsuma Pharmaceuticals Inc 2,570,292 0
2023-01-11 13D/A AMNL / Applied Minerals, Inc. 50,889,636 79,126,740
2022-04-04 13G/A ELYM / Eliem Therapeutics, Inc. 1,703,546 2,128,202
2022-02-25 13G/A STSA / Satsuma Pharmaceuticals Inc 1,769,854 2,570,292
2022-02-14 13G/A SCU / Sculptor Capital Management Inc - Class A 1,490,084 0
2022-02-14 13G STSA / Satsuma Pharmaceuticals Inc 1,769,854
2022-02-14 13G PWP / Perella Weinberg Partners 2,993,365
2022-02-14 13G GLHA / Glass Houses Acquisition Corp - Class A 1,260,198
2022-02-14 13G/A FLMN / Falcon Minerals Corp - Class A 4,758,541 0
2022-02-14 13G ELYM / Eliem Therapeutics, Inc. 1,703,546
2021-02-16 13G SCU / Sculptor Capital Management Inc - Class A 1,490,084
2021-02-16 13G/A FLMN / Falcon Minerals Corp - Class A 4,524,727 4,758,541
2021-02-08 13G FNTCU / FinTech Acquisition Corp. 2,913,419
2021-02-08 13G US7786751088 / Roth CH Acquisition I Co. 963,056
2020-10-22 13D/A AMNL / Applied Minerals, Inc. 48,814,834 50,889,636
2020-03-11 13G/A FLMN / Falcon Minerals Corp - Class A 6,542,752 4,524,727
2020-02-14 13G/A FLMN / Falcon Minerals Corp - Class A 6,537,667 6,542,752
2019-02-14 13G/A FLMN / Falcon Minerals Corp - Class A 6,537,667
2018-11-06 13D/A AMNL / Applied Minerals, Inc. 48,814,834 48,814,834
2018-11-05 13D/A AMNL / Applied Minerals, Inc. 48,092,329 48,814,834
2018-05-03 13D/A AMNL / Applied Minerals, Inc. 48,092,329 48,092,329
2018-05-02 13D/A AMNL / Applied Minerals, Inc. 48,092,329
2018-02-14 13G OSPR / Osprey Energy Acquisition Corp. 2,512,051
2018-02-14 13G/A NRE / NorthStar Realty Europe Corp. 3,747,555 0
2017-12-18 13D/A AMNL / Applied Minerals, Inc. 47,569,310
2017-11-02 13D/A AMNL / Applied Minerals, Inc. 25,662,931
2017-02-14 13G NRE / NorthStar Realty Europe Corp. 3,747,555
2014-11-06 13D/A AMNL / Applied Minerals, Inc. 20,869,565
2013-02-14 13G/A TMS / Tms International Corp. 0
2012-02-14 13G/A TMS / Tms International Corp. 1,165,842
2012-02-14 13G/A EAF / GrafTech International Ltd. 6,828,269
2012-01-03 13D AMNL / Applied Minerals, Inc. 15,000,000